Eli Lilly and Co Analyst Ratings
Truist Securities Reiterates Buy on Eli Lilly and Co, Raises Price Target to $1000
Eli Lilly and Co Analyst Ratings
Jefferies Adjusts Price Target on Eli Lilly to $1,015 From $994
Eli Lilly and Co Analyst Ratings
Eli Lilly and Co Analyst Ratings
Eli Lilly and Co Analyst Ratings
Wells Fargo Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)
Goldman Sachs Adjusts Price Target on Eli Lilly to $785 From $740
Jefferies Adjusts Price Target on Eli Lilly to $925 From $915
Eli Lilly and Co Analyst Ratings
Argus Adjusts Price Target on Eli Lilly to $840 From $770
Redburn Atlantic Adjusts Eli Lilly Price Target to $600 From $540
China Merchants Initiates Eli Lilly at Buy Rating With $852 Price Target
What 23 Analyst Ratings Have To Say About Eli Lilly and Co
Goldman Sachs Adjusts Price Target on Eli Lilly to $740 From $723
Wells Fargo Adjusts Eli Lilly Price Target to $875 From $825
Morgan Stanley Raises Price Target on Eli Lilly to $1,023 From $950 Amid 2024 Guidance Boost, Keeps Overweight Rating
Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Raises Price Target to $885
Eli Lilly and Co Analyst Ratings